To ask the Secretary of State for Health and Social Care, what support his Department is providing to (a) enable early treatment and (b) increase awareness amongst healthcare providers of Kawasaki disease .

NHS Improvement has previously published a Patient Safety Alert for the attention of providers of National Health Service-funded care to emphasise the high risk and atypical presentation of coronary artery aneurysms, coronary thrombosis and myocardial ischaemia or infarction in patients with Kawasaki disease, and to highlight the importance of specialist advice.

Guidance is also available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.

NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.